Scarica l'app Stockscreener
116.84
3.17%
-3.82
Dopo l'orario di chiusura:
116.85
0.010
+0.01%
Precedente Chiudi:
$120.66
Aprire:
$120.53
Volume 24 ore:
485.41K
Relative Volume:
0.82
Capitalizzazione di mercato:
$3.84B
Reddito:
$787.85M
Utile/perdita netta:
$-27.78M
Rapporto P/E:
-134.67
EPS:
-0.8676
Flusso di cassa netto:
$18.75M
1 W Prestazione:
-1.96%
1M Prestazione:
+1.39%
6M Prestazione:
-33.73%
1 anno Prestazione:
-15.15%
Intervallo 1D:
$115.56
$122.78
Intervallo di 1 settimana:
$113.85
$128.77
Portata 52W:
$112.31
$212.00
Irhythm Holdings Inc Stock (IRTC) Company Profile
Nome
Irhythm Holdings Inc
Settore
Industria
Telefono
415-632-5700
Indirizzo
699 8TH STREET, San Francisco, CA
Compare IRTC vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IRTC
Irhythm Holdings Inc
|
116.84 | 3.97B | 787.85M | -27.78M | 18.75M | -0.8676 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Irhythm Holdings Inc Stock (IRTC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-09-23 | Iniziato | Evercore ISI | In-line |
| 2025-08-20 | Iniziato | BofA Securities | Buy |
| 2025-05-02 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-12-03 | Ripresa | Wells Fargo | Equal Weight |
| 2024-10-04 | Iniziato | Goldman | Neutral |
| 2024-06-20 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-02-07 | Iniziato | Wells Fargo | Overweight |
| 2022-11-07 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2022-06-09 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-06 | Iniziato | Wolfe Research | Underperform |
| 2022-02-24 | Aggiornamento | Needham | Hold → Buy |
| 2022-01-18 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-12 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-01-11 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-12-21 | Ripresa | Canaccord Genuity | Buy |
| 2021-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-12-15 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-06-02 | Downgrade | Citigroup | Buy → Neutral |
| 2021-04-13 | Downgrade | BTIG Research | Buy → Neutral |
| 2021-04-12 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-02-26 | Downgrade | Colliers Securities | Buy → Neutral |
| 2021-01-29 | Reiterato | Needham | Hold |
| 2020-11-17 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-09-11 | Iniziato | Needham | Hold |
| 2020-09-02 | Iniziato | Robert W. Baird | Neutral |
| 2020-08-07 | Aggiornamento | Colliers Securities | Neutral → Buy |
| 2020-08-05 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-06 | Iniziato | BTIG Research | Buy |
| 2020-01-10 | Iniziato | William Blair | Outperform |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2019-10-22 | Iniziato | Oppenheimer | Perform |
| 2019-02-20 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2018-09-13 | Reiterato | Canaccord Genuity | Buy |
| 2018-09-06 | Iniziato | Chardan Capital Markets | Buy |
| 2018-08-02 | Aggiornamento | Dougherty & Company | Sell → Neutral |
| 2018-07-16 | Downgrade | Dougherty & Company | Neutral → Sell |
| 2017-12-01 | Iniziato | Dougherty & Company | Neutral |
Mostra tutto
Irhythm Holdings Inc Borsa (IRTC) Ultime notizie
IRTC (NASDAQ) director files Form 144 to sell 5,312 shares via exercise - Stock Titan
Net current asset value per share of iRhythm Holdings, Inc. – LSE:0A7L - TradingView
Will Strong Q1 Results And New Zio Data Change iRhythm Holdings' (IRTC) Narrative - Sahm
Here's why you should retain IRTC stock in your portfolio for now - MSN
IRTC SEC FilingsiRhythm Holdings, Inc 10-K, 10-Q, 8-K Forms - Stock Titan
iRhythm Holdings, Inc. (IRTC) reports Q1 loss, tops revenue estimates - MSN
Sands Capital (IRTC) files Schedule 13G/A amendment on iRhythm ownership - Stock Titan
iRhythm stock rises on Medicare coverage update (IRTC:NASDAQ) - Seeking Alpha
Wall Street analysts predict a 57.21% upside in iRhythm Hldgs (IRTC): Here's what you should know - MSN
iRhythm Holdings CTO Lawrence Lee sells $122,491 in stock By Investing.com - Investing.com Nigeria
iRhythm Holdings CTO Lawrence Lee sells $122,491 in stock - Investing.com
iRhythm (NASDAQ: IRTC) CTO sells 1,014 shares to cover RSU tax obligations - Stock Titan
Wall Street Analysts Predict a 57.21% Upside in IRHYTHM HLDGS (IRTC): Here's What You Should Know - Yahoo Finance
Why iRhythm Holdings, Inc. (IRTC) is a top momentum stock for the long term - MSN
iRhythm Holdings, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:IRTC) 2026-05-04 - Seeking Alpha
IRTC Stock Up on Q1 Earnings & Revenue Beat, FY26 Outlook Raised - Zacks Investment Research
Citi Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Raises Target Price to $157 - Moomoo
IRhythm Holdings, Inc. (IRTC) Stock Analysis: Is A 52.44% Upside Just Around The Corner? - DirectorsTalk Interviews
US$184: That's What Analysts Think iRhythm Holdings, Inc. (NASDAQ:IRTC) Is Worth After Its Latest Results - Yahoo Finance
iRhythm Technologies (NASDAQ:IRTC) Rating Increased to Buy at Wall Street Zen - MarketBeat
Analysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC) and Apogee Therapeutics (APGE) - The Globe and Mail
iRhythm Holdings, Inc. Q1 2026 Financial Results and Forward-Looking Statements – Form 10-Q Highlights - Minichart
IRTC Maintained by JP Morgan -- Price Target Lowered to $175 - GuruFocus
IRTC Maintained by Canaccord Genuity -- Price Target Lowered to $180 - GuruFocus
IRTC Maintained by Wells Fargo -- Price Target Lowered to $180 - GuruFocus
JPMorgan Chase & Co. Has Lowered Expectations for iRhythm Technologies (NASDAQ:IRTC) Stock Price - MarketBeat
IRTC Maintained by Needham -- Price Target Raised to $255 - GuruFocus
IRTC Maintained by Evercore ISI Group -- Price Target Lowered to $160 - GuruFocus
Oppenheimer Adjusts Price Target on iRhythm Technologies to $185 From $225, Maintains Outperform Rating - marketscreener.com
iRhythm Technologies (NASDAQ:IRTC) Shares Down 6.5% Following Analyst Downgrade - MarketBeat
Wells Fargo & Company Has Lowered Expectations for iRhythm Technologies (NASDAQ:IRTC) Stock Price - MarketBeat
Q1 2026 iRhythm Holdings, Inc Earnings Call Transcript - GuruFocus
iRhythm Technologies (NASDAQ:IRTC) Stock Price Expected to Rise, Needham & Company LLC Analyst Says - MarketBeat
iRhythm Holdings Inc (IRTC) Q1 2026 Earnings Call Highlights: St - GuruFocus
Truist Cuts PT on iRhythm Technologies (IRTC) as Part of Fiscal Q1 Results Preview in MedTech - Insider Monkey
iRhythm forecasts 2026 revenue of $875M-$885M while targeting 12%-13% adjusted EBITDA margin - MSN
iRhythm Holdings Announces First Quarter 2026 Financial Results - The Manila Times
IRhythm Technologies Q1 2026 earnings preview - MSN
IRTC SWOT Analysis: Growth Potential Amid Financial Challenges R - GuruFocus
Transcript : IRhythm Holdings, Inc., Q1 2026 Earnings Call, Apr 30, 2026 - marketscreener.com
Why The Narrative Around iRhythm Holdings (IRTC) Is Shifting After Valuation And DOJ Updates - Yahoo Finance
iRhythm Technologies (NASDAQ:IRTC) Announces Quarterly Earnings Results - MarketBeat
Is iRhythm Holdings (IRTC) 23.9% Undervalued After Q1 2026 Beat? - GuruFocus
iRhythm Holdings, Inc. (IRTC) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
IRhythm Q1 Adjusted Loss Narrows, Revenue Rises - marketscreener.com
(IRTC) iRhythm Expects 2026 Revenue Range $875 Million-$885 Million, vs. FactSet Est of $876.2 Million - marketscreener.com
iRhythm Holdings (NASDAQ: IRTC) grows Q1 2026 sales and turns Adjusted EBITDA positive - Stock Titan
iRhythm Holdings Inc (NASDAQ:IRTC) Beats Q1 Estimates, Raises Guidance, Shares Surge - ChartMill
iRhythm (NASDAQ:IRTC) Posts Better-Than-Expected Sales In Q1 CY2026 - Barchart.com
Earnings Flash (IRTC) iRhythm Holdings, Inc. Posts Q1 Adjusted Loss $0.35 per Share, vs. FactSet Est of $-0.62 - marketscreener.com
Irhythm Holdings Inc Azioni (IRTC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):